Desferrioxamine-chelatable iron, a component of serum non-transferrin-bound iron, used for assessing chelation therapy

Blood

Volumn 97, Issue 3, 2001, Pages 792-798

  Breuer, William ^a   Ermers, Marieke J J ^b   Pootrakul, Pensri ^b   Abramov, Ayala ^b   Hershko, Chaim ^b   Cabantchik, Z Ioav ^b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEFEROXAMINE; TRANSFERRIN;

ADULT; ARTICLE; BLOOD SAMPLING; CATALYSIS; CHELATION THERAPY; CLINICAL ARTICLE; COMPLEX FORMATION; FEMALE; HEMOCHROMATOSIS; HUMAN; IRON THERAPY; LIGAND BINDING; MALE; PRIORITY JOURNAL; RECEPTOR AFFINITY; RISK ASSESSMENT; STOICHIOMETRY; TARGET CELL; THALASSEMIA MAJOR;

EID: 0035254193     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.3.792     Document Type: Article

References (24)

1. The biochemistry of desferrioxamine and its relation to iron metabolism
2. Iron chelators for thalassemia
3. A method for assessing iron chelation in membrane model systems and in living mammalian cells
4. Chelation and mobilization of cellular iron by different classes of chelators
5. Iron removal from transferrin - An experimental study
6. Non-specific serum iron in thalassaemia: An abnormal serum iron fraction of potential toxicity
7. Non-transferrin plasma iron in betathalassaemia/Hb E and haemoglobin H diseases
8. Nontransterrin-bound serum iron in thalassemia and sickle cell patients
9. Serum non-transferrinbound iron in beta-thalassaemia major patients treated with desferrioxamine and L1
10. The assessment of serum non-transferrin bound iron (NTBI) in chelation therapy and iron supplementation
11. Non-transferrin bound iron in plasma or serum from patients with idiopathic hemochromatosis
12. Monitoring of iron(III) removal from biological sources using a novel fluorescent siderophore
13. Kinetics of removal and reappearance of non-transferrin-bound plasma iron with deferoxamine therapy
14. Combined therapy with deferiprone and desferrioxamine
15. Combining deferiprene and desferrioxamine to optimize chelation
16. Iron chelation: Rationale for combination therapy
17. Mode of action of iron chelators as antimalarials. The combined action of desferrioxamine and arylisonicotinoyl-hydrazones
18. Serum iron and iron binding capacity
19. Iron chelators for clinical use
20. A direct method for quantification of non-transferrin-bound iron
21. Quantification of non-transferrin bound iron in the presence of unsaturated transferrin
22. New concepts of iron and aluminum chelation therapy with oral L1 (deferiprone) and other chelators
23. The effect of alpha-ketohydropyridine chelators on transferrin saturation in vitro and in vivo